Visualize how your peptide clears from the body — half-life, steady state, and accumulation for every injection schedule.
Half-Life
~2 h
Time for 50 % to be eliminated
Steady State
~9 h
≈ 4.3 half-lives
Accumulation
×1.00
Cmax at steady state ÷ Cmax first dose
Gone After
~14 h
after last dose
Source: Pickart et al., plasma pharmacokinetics. Research tool. Uses a simplified first-order elimination model and normalizes concentration to % of peak. Not a medical or dosing recommendation. GHK-Cu: ~2 h.
GHK-Cu has a reported half-life of about 2 hours. Under a daily dosing schedule, steady state is reached at roughly 4.3 half-lives — about 9 hours — and accumulation is essentially negligible: each daily dose clears almost fully before the next.
The blue line plots concentration as a percentage of the first-dose peak. The dashed reference line marks the steady-state peak. After the last dose, concentration drops below 1 % of the peak after about 14 hours — seven half-lives.
GHK-Cu is a copper-binding tripeptide studied for skin repair, collagen synthesis, and anti-inflammatory effects. Typical daily doses range from 1 to 4 mg. The very short half-life means each dose is independent, with no meaningful carry-over to the following day.